EquityFlowCompanies › Amplifold

Amplifold

Healthtech · Munich, DE

Spin-off LMU che amplifica fino a 100x la sensibilità dei test a flusso laterale con nanostrutture a DNA origami.

Funding history

DateRoundAmount
Dec 2025Seed
Munich-based Amplifold closed an oversubscribed €5 million seed co-led by Matterwave Ventures and XISTA Science Ventures for ultrasensitive diagnostics with DNA origami.
$5.8M

Investors

Bayern KapitalBecker VenturesMatterwave Venturesb2venturexista science ventures

Similar companies in Healthtech

Explore funding flow on EquityFlow →